Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

Tisagenlecleucel is an autologous anti-CD19 chimeric antigen receptor-T cell therapy with clinically meaningful outcomes demonstrated in patients with relapsed/refractory (r/r) B-cell lymphoma. In a previous pilot study of tisagenlecleucel in r/r follicular lymphoma (FL), 71% of patients achieved a...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Nature Medicine Ročník 28; číslo 2; s. 325 - 332
Hlavní autoři:	Fowler, Nathan Hale, Dickinson, Michael, Dreyling, Martin, Martinez-Lopez, Joaquin, Kolstad, Arne, Butler, Jason, Ghosh, Monalisa, Popplewell, Leslie, Chavez, Julio C., Bachy, Emmanuel, Kato, Koji, Harigae, Hideo, Kersten, Marie José, Andreadis, Charalambos, Riedell, Peter A., Ho, P. Joy, Pérez-Simón, José Antonio, Chen, Andy I., Nastoupil, Loretta J., von Tresckow, Bastian, Ferreri, Andrés José María, Teshima, Takanori, Patten, Piers E. M., McGuirk, Joseph P., Petzer, Andreas L., Offner, Fritz, Viardot, Andreas, Zinzani, Pier Luigi, Malladi, Ram, Zia, Aiesha, Awasthi, Rakesh, Masood, Aisha, Anak, Oezlem, Schuster, Stephen J., Thieblemont, Catherine
Médium:	Journal Article Magazine Article
Jazyk:	angličtina
Vydáno:	New York Nature Publishing Group US 01.02.2022 Nature Publishing Group
Témata:	631/67/1990/291/1621/1915 692/308/2779/109/1941 692/699/1541/1990/291/1621/1915 692/699/67/1059/2325 Adult Adults Antigens Antigens, CD19 Autografts B-cell lymphoma Biomedical and Life Sciences Biomedicine Cancer Research CD19 antigen Cell therapy Chimeric antigen receptors Confidence intervals Cytokines Elara Humans Immune response Immunotherapy, Adoptive - adverse effects Infectious Diseases Life Sciences Lymphocytes Lymphocytes B Lymphocytes T Lymphoma Lymphoma, Follicular - drug therapy Metabolic Diseases Molecular Medicine Neurosciences Neurotoxicity Patients Pharmacokinetics Pilot Projects Receptors, Antigen, T-Cell - therapeutic use Risk groups Safety Safety management Stem cell transplantation Stem cells Survival
ISSN:	1078-8956, 1546-170X, 1546-170X, 1744-7933
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!